HELION BIOTECH ApS: Financial statements 2017
CVR: 31758106
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
HELION BIOTECH ApS (CVR 31758106) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -12,330 and a net result of DKK -13,597 compared with DKK -83,573 the year before. Equity in the 2017 report amounted to DKK 217,979. The solvency ratio was 76%.
- Gross Profit
- DKK -12,330
- Profit/Loss
- DKK -13,597
- Equity
- DKK 217,979
- Total Assets
- DKK 286,831
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -12 t. | -14 t. | 218 t. | - |
| 2016 | - | -82 t. | -84 t. | 932 t. | - |
| 2015 | - | -105 t. | -105 t. | 2.1 mio. | - |
| 2014 | - | 2.9 mio. | 2.2 mio. | 2.5 mio. | - |
| 2013 | - | 524 t. | 389 t. | 582 t. | - |
Official annual report
Keep an eye on HELION BIOTECH ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
HELION BIOTECH ApS has published its annual report for 2016. Gross profit came to DKK -81,551, and the net result was DKK -83,573.
About HELION BIOTECH ApS
HELION BIOTECH ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Per Bo Pedersen Fischer. The board consists of Steffen Thiel (chair), Jens Christian Jensenius and Per Bo Pedersen Fischer. The company is owned by HELION HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -27,115 and a net result of DKK -32,019 compared with DKK -43,895 the year before. Equity in the 2025 report amounted to DKK 117,514.